13FPulse
AN

ANIP ANI PHARMACEUTICALS INC

2026Q2 · CUSIP 00182C103 · Sector: Healthcare & Biotech

Piling in

Net holder growth ranks near the top of the market

Funds that own it
302
Institutions that reported holding it to the SEC
Net increase in holders
+25
Last quarter 277 → now 302
How unusual is that
Top 20%
Stronger buying than 87% of US stocks
What the filings say, in one paragraph

302 funds held ANIP at the end of 2026Q2, up 25 from the quarter before. That is stronger buying than 86.8% of US stocks — among the most piled-into names this quarter. On the business itself, revenue over the last 12 months was $978M(YoY +30.9%), the P/E is 15.9x, return on equity is 18.1%. ANIP has had 16 buying rushes in its history, and the price moved +11.5% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2013Q3: holders=28 2013Q4: holders=33 2014Q1: holders=66 2014Q2: holders=80 2014Q3: holders=72 2014Q4: holders=101 2015Q1: holders=122 2015Q2: holders=121 2015Q3: holders=119 2015Q4: holders=122 2016Q1: holders=121 2016Q2: holders=135 2016Q3: holders=167 2016Q4: holders=153 2017Q1: holders=155 2017Q2: holders=149 2017Q3: holders=141 2017Q4: holders=158 2018Q1: holders=170 2018Q2: holders=179 2018Q3: holders=171 2018Q4: holders=167 2019Q1: holders=186 2019Q2: holders=193 2019Q3: holders=188 2019Q4: holders=169 2020Q1: holders=140 2020Q2: holders=132 2020Q3: holders=115 2020Q4: holders=116 2021Q1: holders=105 2021Q2: holders=117 2021Q3: holders=119 2021Q4: holders=133 2022Q1: holders=124 2022Q2: holders=119 2022Q3: holders=125 2022Q4: holders=126 2023Q1: holders=138 2023Q2: holders=171 2023Q3: holders=186 2023Q4: holders=182 2024Q1: holders=201 2024Q2: holders=202 2024Q3: holders=208 2024Q4: holders=204 2025Q1: holders=227 2025Q2: holders=231 2025Q3: holders=268 2025Q4: holders=282 2026Q1: holders=277 2026Q2: holders=302 -37 -18.5 +0 +18.5 +37 25172318 13Q315Q116Q318Q119Q321Q122Q324Q125Q326Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 16 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2026Q2 Top 20%
2025Q3 Top 10% -4.7% +0.0%
2025Q1 Top 10% +49.8% +36.3%
2024Q1 Top 20% -0.3% -7.9%
2023Q3 Top 20% +13.9% +20.4%
2023Q2 Top 10% -10.4% -3.1%
2023Q1 Top 20% +34.7% +17.5%
2019Q2 Top 20% -18.8% -5.5%

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
161
Change in large funds
+21
Total value they hold
$1.9B
Funds buying for the first time
55
Funds that sold out entirely
30
Price change that quarter
-7.9%
Funds holding puts (bearish)
3
Funds holding calls (bullish)
3

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
15.9
EPS (TTM)
$4.60
EPS YoY
Revenue (TTM)
$1.0B
Revenue YoY
+30.9%
Net margin
11.1%
ROE
18.1%
Debt ratio
60.0%
FCF (TTM)
$173M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2021-09-30: EPS -0.37 2021-12-31: EPS -1.87 2022-03-31: EPS -1.27 2022-06-30: EPS -0.94 2022-09-30: EPS -0.55 2022-12-31: EPS -0.29 2023-03-31: EPS 0.06 2023-06-30: EPS 0.29 2023-09-30: EPS 0.45 2023-12-31: EPS 0.05 2024-03-31: EPS 0.82 2024-06-30: EPS -0.14 2024-09-30: EPS -1.27 2024-12-31: EPS -0.45 2025-03-31: EPS 0.69 2025-06-30: EPS 0.36 2025-09-30: EPS 1.13 2025-12-31: EPS 1.14 2026-03-31: EPS 1.28 2026-06-30: EPS 1.05 0M 133M 266M $M -2.06 -0.32 1.41 2016201720182019202020212022202320242025202606/26 Revenue EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 49 15 60 106 2023202420252026

P/E = close around day 47 after quarter-end ÷ TTM EPS then; this is a consistent valuation date, not the company’s actual filing date; loss quarters hidden

Quarterly free cash flow
-21M25M72M 20162017201820192020202120222023202420252026
Latest quarter $52M (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.